TSI-GSD-210(TSI-GSD-210) - 在研适应症：西马脑炎病毒感染_专利_临床

概要

基本信息

药物类型

生物药

别名-

靶点-

作用机制-

治疗领域

感染神经系统疾病其他疾病

在研适应症

西马脑炎病毒感染

非在研适应症-

原研机构

U S Army Medical Research & Development Command

在研机构

U S Army Medical Research & Development Command

非在研机构-

最高研发阶段临床2期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

2

项与 TSI-GSD-210 相关的临床试验

NCT02466750 / Unknown status临床2期IIT

Phase 2 Open-Label Safety and Immunogenicity Study of the Western Equine Encephalitis (WEE) Vaccine, Inactivated, Dried, TSI-GSD 210, Lot 3-1-92, in Healthy Adult Subjects at Risk of Exposure to Western Equine Encephalitis Virus

This study is being conducted to collect safety and immunogenicity data for the WEE vaccine, TSI-GSD 210. Enrollment in this protocol is offered for personnel who enter areas where this virus is used in research or is endemic (an area where this disease process is found to occur frequently).

开始日期2015-12-15

申办/合作机构

U S Army Medical Research & Development Command

NCT01159561 / Completed临床1期IIT

Phase 1 Study to Evaluate the Safety and Immunogenicity of the Western Equine Encephalitis (WEE) Vaccine, Inactivated, TSI-GSD 210, Lot 3-1-92, In Healthy Adults

This study is designed to determine the safety and immunogenicity of WEE Vaccine Lot number 3-1-92.

开始日期2010-02-01

申办/合作机构

U S Army Medical Research & Development Command

100 项与 TSI-GSD-210 相关的临床结果

登录后查看更多信息

100 项与 TSI-GSD-210 相关的转化医学

登录后查看更多信息

100 项与 TSI-GSD-210 相关的专利（医药）

登录后查看更多信息

100 项与 TSI-GSD-210 相关的药物交易

登录后查看更多信息